LON:SPI - Spire Healthcare Group Share Price, Forecast & News

Spire Healthcare Group trades on the London Stock Exchange (LON) under the ticker symbol "SPI."

Spire Healthcare Group announced a dividend on Monday, September 16th. Investors of record on Thursday, November 14th will be given a dividend of GBX 1.30 per share on Tuesday, December 10th. This represents a dividend yield of 1.07%. The ex-dividend date is Thursday, November 14th. The official announcement can be viewed at this link. View Spire Healthcare Group's Dividend History.

Spire Healthcare Group PLC (LON:SPI) posted its earnings results on Friday, March, 2nd. The company reported $14.40 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $14.60 by $0.20. The firm had revenue of $931.70 million for the quarter. View Spire Healthcare Group's Earnings History.

Spire Healthcare Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Spire Healthcare Group.

10 equities research analysts have issued 12 month price objectives for Spire Healthcare Group's stock. Their forecasts range from GBX 75 to GBX 163. On average, they expect Spire Healthcare Group's stock price to reach GBX 132.44 in the next twelve months. This suggests that the stock has a possible downside of 5.0%. View Analyst Price Targets for Spire Healthcare Group.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Spire Healthcare Group in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Spire Healthcare Group.

Media coverage about SPI stock has been trending somewhat negative this week, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Spire Healthcare Group earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Spire Healthcare Group.

Some companies that are related to Spire Healthcare Group include Healius (HLS), Rhoen Klinikum (RHK), CareTech (CTH), Virtus Health (VRT), Pacific Smiles Group (PSQ), Georgia Healthcare Group (GHG), Assure (IOM), CENTRIC HEALTH (CHH), Sanara MedTech (SMTI), Totally (TLY), Konekt (KKT), Brain Resource (BRC), Nobilis Health (HLTH), Venn Life Sciences (VENN) and Wellness and Beauty (WNB).

Based on aggregate information from My MarketBeat watchlists, some companies that other Spire Healthcare Group investors own include Tenet Healthcare (THC), Mediclinic International (MDC), Kindred Biosciences (KIN), Merlin Entertainments (MERL), National Grid (NG), Playtech (PTEC), Abcam (ABC), 888 Holdings Public (888), Gem Diamonds (GEMD) and Hurricane Energy (HUR).

Shares of SPI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of SPI stock can currently be purchased for approximately GBX 139.40.

Spire Healthcare Group has a market capitalization of £559.11 million and generates £947.10 million in revenue each year. Spire Healthcare Group employs 11,770 workers across the globe.View Additional Information About Spire Healthcare Group.

The official website for Spire Healthcare Group is http://investors.spirehealthcare.com/.

Spire Healthcare Group's mailing address is 3 Dorset Rise, LONDON, EC4Y 8EN, United Kingdom. The company can be reached via phone at 44 20 7427 9000.